Stocks and Investing
Stocks and Investing
Mon, July 26, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robyn Karnauskas Initiated (ABBV) at Strong Buy and Held Target at $118 on, Jul 26th, 2021
Robyn Karnauskas of Truist Securities, Initiated "AbbVie Inc." (ABBV) at Strong Buy and Held Target at $118 on, Jul 26th, 2021.
Robyn has made no other calls on ABBV in the last 4 months.
There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 1 agrees with Robyn's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $113 on, Wednesday, May 19th, 2021
These are the ratings of the 6 analyists that currently disagree with Robyn
- Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $126 on, Wednesday, May 12th, 2021
- Tim Anderson of "Wolfe Research" Maintained at Buy with Increased Target to $127 on, Monday, May 3rd, 2021
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $128 on, Monday, May 3rd, 2021
- Daniel Busby of "RBC Capital" Reiterated at Buy and Held Target at $135 on, Monday, May 3rd, 2021
- Gary Nachman of "BMO Capital" Maintained at Buy with Increased Target to $129 on, Monday, May 3rd, 2021
- Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $144 on, Tuesday, March 30th, 2021
Contributing Sources